Diagnostic Accuracy of Magnetic Resonance Spectroscopy in Diagnosing Carcinoma Prostate
AbstractObjective: To determine the diagnostic accuracy of magnetic resonance spectroscopy (MRS) in detection of prostate cancer, rendering histopathology as gold standard.
MethodsDescriptive, Cross sectional study conducted from January 2016 to June 2017. Total 206 male patients with clinical suspicion of carcinoma prostate were included in study. Magnetic resonance spectroscopy (MRS) was performed in each patient. The findings were correlated with histopathology report to confirm the diagnosis.
Results Out of 206 cases, MRS supported the diagnosis of prostate cancer in 120 (58.25%) patients. Histopathology confirmed prostate cancer in 124 (60.19%) cases whereas 82 (39.81%) patients revealed no prostate cancer. Overall sensitivity, specificity and diagnostic accuracy of magnetic resonance spectroscopy (MRS) in diagnosing carcinoma prostate was 87.10%, 85.37% and 86.41% respectively.
Conclusion Magnetic resonance spectroscopy has high diagnostic accuracy in diagnosing prostate cancer.
Keywords:Magnetic resonance spectroscopy has high diagnostic accuracy in diagnosing prostate cancer.
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments email@example.com